Announced Tue, 14 Apr · 15:50 IST

Compliance Certificate Under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-5.3%1-day move

₹57.01

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————-5.3-1.9-1.0-5.3+3.5-1.7-0.9-0.1-31.0-35.3

Up moveDown movePending

AI summary

Bacil Pharma Ltd has filed a compliance certificate under SEBI (Depositories and Participants) Regulations, 2018. This filing pertains to Regulation 74(5), which governs the dematerialization and rematerialization of securities. The document confirms the company's compliance with depository-related regulatory requirements. However, the detailed content of the certificate is not accessible from the source provided.

Likely market impact

This is a routine regulatory compliance filing related to securities dematerialization. It does not have direct implications for the stock price or shareholder value but indicates the company is maintaining required SEBI compliance standards.